These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 3103410

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 23. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ.
    Eur Heart J; 1995 Dec 01; 16(12):1930-5. PubMed ID: 8682029
    [Abstract] [Full Text] [Related]

  • 24. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G.
    Acta Cardiol; 1995 Dec 01; 50(2):125-34. PubMed ID: 7610735
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency.
    Barranco F, Sanchez M, Rodriguez J, Guerrero M.
    Intensive Care Med; 1994 Dec 01; 20(1):42-4. PubMed ID: 8163757
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M, Orning OM.
    Tidsskr Nor Laegeforen; 1989 Aug 20; 109(23):2309-10. PubMed ID: 2505404
    [Abstract] [Full Text] [Related]

  • 28. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B.
    Cardiol Young; 2012 Aug 20; 22(4):372-80. PubMed ID: 22008551
    [Abstract] [Full Text] [Related]

  • 29. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.
    Am Heart J; 1995 Apr 20; 129(4):739-48. PubMed ID: 7900626
    [Abstract] [Full Text] [Related]

  • 30. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS, Kim SS, Ruffy R.
    Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG.
    Am J Cardiol; 1989 Mar 15; 63(11):693-6. PubMed ID: 2493733
    [Abstract] [Full Text] [Related]

  • 33. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

  • 34. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M, Warin JF, Goldrach S, Le Métayer P, Guillem JP, Blanchot P.
    Arch Mal Coeur Vaiss; 1988 Dec 01; 81(12):1493-8. PubMed ID: 3147639
    [Abstract] [Full Text] [Related]

  • 35. Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias.
    Bru P, Cointe R, Paganelli F, Ricard P, Lévy S.
    Cardiovasc Drugs Ther; 1995 Feb 01; 9(1):85-8. PubMed ID: 7786839
    [Abstract] [Full Text] [Related]

  • 36. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A, Kaya B, Bornaun H, Acar DK, Avci ME, Bestel A, Yildirim G.
    J Matern Fetal Neonatal Med; 2018 Feb 01; 31(4):407-412. PubMed ID: 28114840
    [Abstract] [Full Text] [Related]

  • 37. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 01; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 38. Flecainide acetate in the treatment of tachycardias associated with Mahaim fibres.
    Lau CP, Davies DW, Mehta D, Ward DW, Camm AJ.
    Eur Heart J; 1987 Aug 01; 8(8):832-9. PubMed ID: 3117552
    [Abstract] [Full Text] [Related]

  • 39.
    Hafeez Y, Quintanilla Rodriguez BS, Ahmed I, Grossman SA, Haddad LM.
    ; 2024 01 01. PubMed ID: 33760543
    [Abstract] [Full Text] [Related]

  • 40. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA.
    Circulation; 2011 Oct 18; 124(16):1747-54. PubMed ID: 21931080
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.